The Board of Directors of the Company in its meeting held on Friday, 13th February, 2026 has considered and approved the following business:- 1. The Consolidated and Standalone Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 0.3 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TCM Limited reported unaudited results for Q3 FY26 and the nine months ended 31 December 2025, approved at the board meeting on 13 February 2026. Standalone revenue from operations fell to ₹520.15 lakhs in Q3 from ₹588.79 lakhs a year ago, while nine-month revenue dropped about 24% to ₹1,326.53 lakhs from ₹1,744.85 lakhs. The company swung to a standalone loss of ₹235.39 lakhs for nine months, compared to a profit of ₹314.92 lakhs in the full previous financial year; consolidated nine-month loss widened to ₹436.06 lakhs from ₹262.66 lakhs. The Manufacturing segment turned loss-making in Q3 at ₹(16.28) lakhs and Real Estate revenue fell sharply to ₹30.25 lakhs from ₹210.29 lakhs YoY. The statutory auditors (SGM & Associates LLP) issued an unmodified (clean) limited review report on both standalone and consolidated results, and the company disclosed a binding MoU to acquire 100% of Better Feeds Private Limited for ₹765 lakhs, with an advance of ₹108.23 lakhs already paid.
Negative for shareholders — revenue is declining meaningfully and the company has slipped from a full-year profit into multi-quarter losses, with margin compression across segments; however, the clean auditor opinion and absence of any going-concern flag limit the immediate downside surprise. Watch for further deterioration in the Manufacturing and Educational segments and progress on the Better Feeds acquisition.